Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak

    ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak

    Medical Dialogues Bureau21 Feb 2020 12:22 PM IST
    According to Icra research, domestic API manufacturers have an inventory of one-two months, which should adequately support their production till...
    FDA grants priority review to Roches Tecentriq monotherapy as first-line treatment in certain lung cancer cases

    FDA grants priority review to Roche's Tecentriq monotherapy as first-line treatment in certain lung cancer cases

    Medical Dialogues Bureau20 Feb 2020 2:20 PM IST
    Basel: Roche announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and...
    USFDA, Indian Government Join hands to clamp down on Illicit Medical Products

    USFDA, Indian Government Join hands to clamp down on Illicit Medical Products

    Medical Dialogues Bureau19 Feb 2020 12:54 PM IST
    US: The U.S. Food and Drug Administration today announced that its first bilateral enforcement operation with the Government of India stopped...
    USFDA completes inspection of Lupins Aurangabad facility

    USFDA completes inspection of Lupin's Aurangabad facility

    Medical Dialogues Bureau17 Feb 2020 4:18 PM IST
    Mumbai: Pharma major Lupin Limited (Lupin) announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried...
    USFDA seeks voluntary action at Dr Reddys Duvvada facility

    USFDA seeks voluntary action at Dr Reddy's Duvvada facility

    Medical Dialogues Bureau17 Feb 2020 3:10 PM IST
    New Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra...
    Granules India gets tentative USFDA nod for generic version of Mucinex ER Tablets

    Granules India gets tentative USFDA nod for generic version of Mucinex ER Tablets

    Medical Dialogues Bureau15 Feb 2020 11:00 AM IST
    New Delhi: Drugmaker Granules India Limited recently announced that the company has received tentative approval from the US Food & Drug...
    Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories

    Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories

    Farhat Nasim13 Feb 2020 1:04 PM IST
    "Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use...1000 mg," the drug firm said in a...
    Lupin Pithampur unit gets 2 USFDA observations

    Lupin Pithampur unit gets 2 USFDA observations

    Medical Dialogues Bureau13 Feb 2020 12:52 PM IST
    The inspection of the company's Pithampur Unit-I facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in...
    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    Medical Dialogues Bureau13 Feb 2020 10:00 AM IST
    New York: MEDICREA, pioneering the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants...
    Novartis cancer therapy MET inhibitor capmatinib granted USFDA priority review

    Novartis cancer therapy MET inhibitor capmatinib granted USFDA priority review

    Medical Dialogues Bureau13 Feb 2020 9:45 AM IST
    Capmatinib (INC280) is an investigational, oral, potent and selective MET inhibitor licensed to Novartis by Incyte Corporation in 2009. Under the...
    Granules India gets tentative USFDA nod for generic Colchicine capsules

    Granules India gets tentative USFDA nod for generic Colchicine capsules

    Medical Dialogues Bureau12 Feb 2020 2:34 PM IST
    New Delhi: Drug firm Granules India on Tuesday said it has received tentative approval from the US health regulator for its generic Colchicine...
    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA

    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA

    Medical Dialogues Bureau12 Feb 2020 1:10 PM IST
    "The company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the new drug application...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok